An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention
- PMID: 20868401
- DOI: 10.1111/j.1529-8019.2010.01350.x
An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention
Abstract
Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection transmitted by genital contact that can cause a variety of anogenital diseases, including warts (condyloma), dysplasia (cervical, vaginal, vulvar, anal), and squamous cell carcinoma. A number of treatment modalities are available to treat anogenital warts, both patient- and provider-applied. Treatment is efficacious, but lesions can recur. Bivalent and quadrivalent vaccines are approved to prevent HPV infection. Both are indicated to prevent cervical cancer, while the quadrivalent vaccine is also approved to prevent vaginal/vulvar cancers as well as genital warts in males and females. Providers should clearly explain the natural history and potential sequelae of HPV disease, counsel patients on prevention strategies, and recommend vaccination as an effective method of prevention to their patients.
© 2010 Wiley Periodicals, Inc.
Similar articles
-
New quadrivalent HPV vaccine developments.Postgrad Med. 2008 Nov;120(4):14-6. doi: 10.3810/pgm.2008.11.1929. Postgrad Med. 2008. PMID: 19020361 Review.
-
[AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].Akush Ginekol (Sofiia). 2015;54 Suppl 1:25-31. Akush Ginekol (Sofiia). 2015. PMID: 26137767 Bulgarian.
-
Epidemiology and natural history of genital human papillomavirus infection.J Am Osteopath Assoc. 2006 Mar;106(3 Suppl 1):S2-8. J Am Osteopath Assoc. 2006. PMID: 16729554 Review.
-
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.Eur J Cancer. 2015 Sep;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001. Epub 2015 Jun 26. Eur J Cancer. 2015. PMID: 26121913
-
Prophylactic HPV vaccines: new interventions for cancer control.Vaccine. 2008 Nov 18;26(49):6244-57. doi: 10.1016/j.vaccine.2008.07.056. Epub 2008 Aug 9. Vaccine. 2008. PMID: 18694795 Review.
Cited by
-
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases.Vaccines (Basel). 2020 Oct 1;8(4):568. doi: 10.3390/vaccines8040568. Vaccines (Basel). 2020. PMID: 33019516 Free PMC article. Review.
-
Sinecatechins Ointment, 15% for the Treatment of External Genital and Perianal Warts: Proceedings of an Expert Panel Roundtable Meeting.J Clin Aesthet Dermatol. 2016 Mar;9(3 Suppl 1):S2-S15. Epub 2016 Mar 1. J Clin Aesthet Dermatol. 2016. PMID: 29844847 Free PMC article. No abstract available.
-
The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.Front Immunol. 2024 May 15;15:1407649. doi: 10.3389/fimmu.2024.1407649. eCollection 2024. Front Immunol. 2024. PMID: 38812510 Free PMC article. Review.
-
Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of Bioactive Compounds from Various Indonesian Medicinal Plants as Potential Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer Development.Trop Life Sci Res. 2025 Mar;36(1):1-24. doi: 10.21315/tlsr2025.36.1.1. Epub 2025 Mar 30. Trop Life Sci Res. 2025. PMID: 40276043 Free PMC article.
-
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia.Sci Rep. 2024 Jan 10;14(1):958. doi: 10.1038/s41598-024-51594-7. Sci Rep. 2024. PMID: 38200092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical